Market Size of Cytomegalovirus Treatment Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 6.10 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Cytomegalovirus Treatment Market Analysis
The Cytomegalovirus (CMV) Treatment Market is anticipated to register a CAGR of 6.1% during the forecast period.
COVID-19 significantly impacted the cytomegalovirus treatment market during the pandemic period. The patients with cytomegalovirus infection were more prone to COVID-19 than the patients without the infection, thereby impacting the demand for treatment during the COVID-19 outbreak. For instance, the article published in the Journal of Medical Virology published in October 2021 mentioned that patients with cytomegalic virus infection might have presented with more severe COVID-19 upon admission to healthcare centers than those without the infections. Such a high risk of cytomegalovirus is expected to have a notable impact on the market's growth over the forecast period. However, the reduction of COVID-19 cases in the post-pandemic period is expected to contribute to the growth of the market owing to the rising focus on the development of advanced treatments for cytomegalovirus, thereby boosting the market growth over the forecast period.
The rising prevalence of CMV retinitis and congenital CMV infection, extending the application range of CMV treatment, increasing initiatives for creating awareness regarding treatments and diagnosis of these conditions, and increasing clinical trial studies for the development of new drugs are likely to be the factors responsible for the growth of this market.
For instance, as per the CDC data updated in May 2022, in the United States, around 150 infants are born with cytomegalovirus infections every year, and a few of them have long-term health issues. CMV infection in infants generates an attenuated interferon response associated with a similar infection in the adult. As per the same source, cytomegalovirus infection and the risk of reactivation of cytomegalovirus infection have been reported during pregnancy and can also lead to congenital CMV infection. Thus, the rising disease burden is expected to drive the demand for effective treatment options, thereby contributing to the market's growth.
In addition, the increasing prevalence of viral infections among AIDS patients due to weakened immune systems is expected to drive the demand for cytomegalovirus drugs. For instance, according to the WHO updates from November 2022, an estimated 38.4 million people were living with HIV, with 36.7 million adults and 1.7 million children affected with HIV in 2021. Since one of the most common Opportunistic Infections (OIs) documented in people with human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) is Cytomegalovirus (CMV), the demand for cytomegalovirus treatment is anticipated to grow over the coming years.
Furthermore, the rising product approvals and product developments by various key market players are also expected to drive the market's growth in the forecast period. For instance, in May 2022, Hologic, Inc. announced that the US FDA approved its Aptima CMV Quant assay to quantify the viral load of Cytomegalovirus (CMV) in patients with solid organ or stem cell transplants. Similarly, in October 2021, Moderna, Inc. announced the first participant had been dosed in the Phase III pivotal registration study of mRNA-1647, the company's Cytomegalovirus (CMV) vaccine candidate. This study is known as CMVictory.
However, adverse effects and risks related to cytomegalovirus drugs may hamper the demand for the Cytomegalovirus (CMV) Treatment Market.
Cytomegalovirus Treatment Industry Segmentation
As per the scope of the report, Cytomegalovirus (CMV) is a contagious virus that spreads via bodily secretions in people of all ages; however, a healthy person's immune system usually keeps the virus from causing illness.
The Cytomegalovirus Treatment Market is segmented by Application (Stem Cell Transplantation, Organ Transplantation, Congenital CMV infection, and Other Applications), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and E-commerce), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (USD million) for the above segments.
| By Application | |
| Stem Cell Transplantation | |
| Organ Transplantation | |
| Congenital CMV Infection | |
| Other Applications |
| By Distribution Channel | |
| Hospital pharmacies | |
| Retail Pharmacies | |
| E-commerce |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Cytomegalovirus Treatment Market Size Summary
The Cytomegalovirus (CMV) Treatment Market is poised for significant growth, driven by a combination of factors including the rising prevalence of CMV-related conditions and advancements in treatment options. The market is expected to expand steadily over the forecast period, with increased focus on developing advanced therapies and raising awareness about CMV infections. The impact of COVID-19 on the market was notable, as patients with CMV infections faced higher risks during the pandemic, which influenced treatment demand. However, the post-pandemic period is anticipated to see a resurgence in market growth due to the ongoing development of innovative treatments. The market's expansion is further supported by the increasing incidence of CMV retinitis and congenital CMV infections, alongside a surge in clinical trials aimed at introducing new therapeutic solutions.
North America is projected to maintain a substantial share of the global CMV treatment market, attributed to the high incidence of CMV infections, heightened consumer awareness, and the presence of key industry players. The region's market growth is bolstered by frequent product approvals and developments, which are crucial in addressing the demand for effective treatments. The competitive landscape of the market is characterized by the involvement of both local and global players, with major companies actively participating in research and development to enhance treatment options. The market's trajectory is expected to be influenced by ongoing regulatory approvals and the introduction of novel therapies, which will play a pivotal role in meeting the growing demand for CMV treatments.
Cytomegalovirus Treatment Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Growing Awareness and Introduction of New Drug Therapies
-
1.2.2 High Prevalence of Infectious Diseases Among AIDS Patient
-
1.2.3 Upsurge in Patient Pool of CMV Retinitis and Congenital CMV Infection
-
-
1.3 Market Restraints
-
1.3.1 Adverse Effects and Risks Related to Cytomegalovirus Drugs
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Application
-
2.1.1 Stem Cell Transplantation
-
2.1.2 Organ Transplantation
-
2.1.3 Congenital CMV Infection
-
2.1.4 Other Applications
-
-
2.2 By Distribution Channel
-
2.2.1 Hospital pharmacies
-
2.2.2 Retail Pharmacies
-
2.2.3 E-commerce
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle-East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle-East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Cytomegalovirus Treatment Market Size FAQs
What is the current Cytomegalovirus Treatment Market size?
The Cytomegalovirus Treatment Market is projected to register a CAGR of 6.10% during the forecast period (2024-2029)
Who are the key players in Cytomegalovirus Treatment Market?
Merck & Co., Inc , Thermo Fisher Scientific , Teva Canada Limited , Gilead Sciences and F. Hoffmann-La Roche Ltd are the major companies operating in the Cytomegalovirus Treatment Market.
